About Bioatrix
Bioatrix is a company based in Sydney (Australia) founded in 2012 was acquired by ZZ Biotech in January 2016. Bioatrix operates in a competitive market with competitors including QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.
- Headquarter Sydney, Australia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
ZZ Biotech
(Jan 12, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bioatrix
Detailed funding history for Bioatrix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bioatrix
Bioatrix has secured backing from 1 investor. Prominent investors backing the company include ZZ Biotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Genetically engineered proteins for stroke and brain disorders are developed.
|
Locked | Locked | Locked |
Investor details for Bioatrix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioatrix
Investment portfolio details for Bioatrix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioatrix
Detailed financials for Bioatrix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioatrix Comparisons
Peer comparison for Bioatrix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioatrix
Bioatrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| Locked | Locked | Locked |
Powdered fibrin sealant for surgical bleeding
|
|
| Locked | Locked | Locked |
Topical formulations for corneal wounds, ulcers, and scars are developed.
|
Detailed competitors of Bioatrix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioatrix
Complete news archive for Bioatrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioatrix
Bioatrix was founded in 2012.
Bioatrix is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Bioatrix is a regenerative medicine company primarily focussed on developing protein-based products for wound healing. It has licensed the technology based on the Activated Protein C (aPC) from the Sydney University. These proteins claim to have shown potential as a treatment for inflammatory skin diseases, such as psoriasis and eczema, and hypertrophic scarring. The company is currently working on phase 2 trials wound healing. In December 2015, ZZ Biotech acquired Bioatrix and since then it is working as its subsidiary.
Bioatrix's top competitors include Ilya Pharma, QBiotics and Tempo Therapeutics.
Bioatrix has 1 investor. Key investors include ZZ Biotech.